# India's TDB signs ₹86 crore financing agreement for Peptris drug programme

_Published Monday, October 12, 2026 at 7:18 AM EDT · AI, Science · Latest · Tier 2 — Notable_

![India's TDB signs ₹86 crore financing agreement for Peptris drug programme — Primary](https://cdn.expresspharma.in/wp-content/uploads/2020/06/13205606/stamp-e1726045571234.jpg)

India's Technology Development Board has signed an agreement to provide Peptris Technologies with ₹86 crore for its AI-driven drug development programme through optionally convertible debt. The VIGOR project has a total cost of ₹172 crore and covers four drug candidates.

Over three years, the programme aims to move the candidates from Technology Readiness Level 4 to Level 6 through preclinical validation, formulation work and preparation for clinical trials. Clinical trial preparation and initiation activities are subject to scientific and regulatory requirements.

## Sources

- [Express Pharma](https://www.expresspharma.in/tdb-approves-%E2%82%B986-crore-rdi-support-for-peptris-ai-driven-drug-development/)

---
Canonical: https://techandbusiness.org/newswire/_DvIwGwOohaMz00hyMYoHb
Published: 2026-10-12T11:18:53.852Z
Story chronology: 2026-10-12T08:51:56.000Z
Retrieved: 2026-10-12T13:15:35.064Z
Publisher: Tech & Business (techandbusiness.org)